Last reviewed · How we verify
PERFLEXANE
At a glance
| Generic name | PERFLEXANE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 2002 |
Approved indications
Common side effects
Key clinical trials
- Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anteriorly
- Fluid Filled Lung Oxygenation Assistance Trial (PHASE1)
- Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia (PHASE2)
- Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms. (PHASE2)
- Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis (PHASE2)
- Measuring Cognitive Enhancement During Hyperbaric Oxygen Treatments (NA)
- Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma (PHASE2)
- Phase1, Placebo-Controlled, Randomized, Double-blind, Single-ascending Dose Study in Healthy Subjects. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |